| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 37 |
| 1 | METHOTREXATE SODIUM | 35 |
| 2 | METHOTREXATE | 29 |
| 3 | TACROLIMUS | 25 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 5 | TACROLIMUS OINTMENT 0.1% | 25 |
| 6 | CYCLOPHOSPHAMIDE | 24 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 9 | ADALIMUMAB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RETIFANLIMAB-DLWR | 6 | 0.0833 |
| 1 | HYDROCORTISONE 2.5% | 1 | 0.0062 |
| 2 | BREXUCABTAGENE AUTOLEUCEL | 12 | 0.0056 |
| 3 | BRODALUMAB | 6 | 0.0029 |
| 4 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 5 | CARMUSTINE | 11 | 0.0023 |
| 6 | IBALIZUMAB | 1 | 0.0019 |
| 7 | MARAVIROC | 4 | 0.0017 |
| 8 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 9 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 6 | 0.0029 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0017 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 18 | 0.0008 |
| 4 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 5 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 8 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 9 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |